Bellevue Asset Management, LLC Bristol Myers Squibb CO Transaction History

Bellevue Asset Management, LLC

$194 Million
Q3 2024

A detailed history of Bellevue Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bellevue Asset Management, LLC holds 5,455 shares of BMY stock, worth $310,062. This represents 0.15% of its overall portfolio holdings.

Number of Shares

5,455

Previous 7,441 26.69%

Holding current value

$310,062

Previous $309,000 8.74%

% of portfolio

0.15%

Previous 0.17%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$39.66 - $51.75 $78,764 - $102,775	-1,986 Reduced 26.69%	5,455 $282,000
Q2 2024 Jul 31, 2024	SELL	$40.25 - $52.99 $48,903 - $64,382	-1,215 Reduced 14.04%	7,441 $309,000
Q1 2024 Apr 26, 2024	SELL	$47.98 - $54.4 $17,752 - $20,128	-370 Reduced 4.1%	8,656 $469,000
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $1,987 - $2,371	-41 Reduced 0.45%	9,026 $463,000
Q3 2023 Oct 25, 2023	BUY	$57.89 - $64.73 $463 - $517	8 Added 0.09%	9,067 $526,000
Q2 2023 Jul 31, 2023	BUY	$63.71 - $70.74 $6,816 - $7,569	107 Added 1.2%	9,059 $579,000
Q1 2023 May 09, 2023	SELL	$65.71 - $74.53 $149,687 - $169,779	-2,278 Reduced 20.28%	8,952 $620,000
Q4 2022 Jan 23, 2023	SELL	$68.48 - $81.09 $64,645 - $76,548	-944 Reduced 7.75%	11,230 $0
Q3 2022 Nov 07, 2022	BUY	$0.13 - $76.84 $0 - $461	6 Added 0.05%	12,174 $857,000
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $6,826 - $7,518	-94 Reduced 0.77%	12,168 $942,000
Q1 2022 May 11, 2022	SELL	$61.48 - $73.72 $18,075 - $21,673	-294 Reduced 2.34%	12,262 $899,000
Q4 2021 Feb 03, 2022	SELL	$53.63 - $62.52 $489,427 - $570,557	-9,126 Reduced 42.09%	12,556 $783,000
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $3,195 - $3,742	-54 Reduced 0.25%	21,682 $1.3 Million
Q2 2021 Aug 09, 2021	SELL	$61.91 - $67.42 $7,057 - $7,685	-114 Reduced 0.52%	21,736 $1.45 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $5,637 - $6,340	-95 Reduced 0.43%	21,850 $1.38 Million
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $11,201 - $12,693	-194 Reduced 0.88%	21,945 $1.43 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $71,098 - $78,786	-1,238 Reduced 5.3%	22,139 $1.34 Million
Q2 2020 Jul 31, 2020	SELL	$54.82 - $64.09 $23,024 - $26,917	-420 Reduced 1.76%	23,377 $1.38 Million
Q1 2020 May 13, 2020	BUY	$46.4 - $67.43 $6,960 - $10,114	150 Added 0.63%	23,797 $1.49 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $1.16 Million - $1.52 Million	23,647 New	23,647 $1.52 Million

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Asset Management, LLC with notifications on news.

Account

Bellevue Asset Management, LLC Bristol Myers Squibb CO Transaction History